Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB-ALIP for Product used for unknown indication: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 16 adverse event reports in the FDA FAERS database where NIRSEVIMAB-ALIP was used for Product used for unknown indication.

Most Reported Side Effects for NIRSEVIMAB-ALIP

Side Effect Reports % Deaths Hosp.
Drug ineffective 173 22.1% 1 127
Respiratory syncytial virus bronchiolitis 135 17.2% 1 72
Bronchiolitis 83 10.6% 0 65
Incorrect dose administered 80 10.2% 0 2
Respiratory syncytial virus infection 76 9.7% 2 54
Pyrexia 54 6.9% 0 29
Cough 45 5.8% 0 25
Respiratory syncytial virus test positive 36 4.6% 1 30
Extra dose administered 30 3.8% 0 0
Product storage error 30 3.8% 0 0
Rash 25 3.2% 0 6
Oxygen therapy 22 2.8% 0 22
Product administered to patient of inappropriate age 20 2.6% 0 0
Respiratory distress 17 2.2% 0 14
Urticaria 17 2.2% 0 4

Other Indications for NIRSEVIMAB-ALIP

Respiratory syncytial virus immunisation (170) Antiviral prophylaxis (137) Immunisation (107) Prophylaxis (26) Respiratory syncytial virus infection (22)

Other Drugs Used for Product used for unknown indication

OXYCODONE (129,391) ADAPALENE (91,681) APIXABAN (88,417) ETANERCEPT (71,866) SACUBITRIL\VALSARTAN (69,693) ACETAMINOPHEN (68,427) AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206) ADALIMUMAB (63,549) EVOLOCUMAB (60,696) MORPHINE (59,440)

Related Pages

NIRSEVIMAB-ALIP Full Profile All Product used for unknown indication Drugs NIRSEVIMAB-ALIP Demographics NIRSEVIMAB-ALIP Timeline